NEW
Lorviqua

Lorviqua ATC Classification

lorlatinib

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma
Full Prescribing Info
ATC Classification
L01ED05 - lorlatinib ; Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in